Reuters: Global Markets: Heart valve maker Edwards forecasts strong 2013, shares rise

Reuters: Global Markets Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

Heart valve maker Edwards forecasts strong 2013, shares rise Dec 4th 2012, 15:47 Tue Dec 4, 2012 10:47am EST (Reuters) - Edward Lifesciences Corp (EW.N) on Tuesday issued an optimistic outlook for 2013, projecting strong sales growth led by its artificial heart valve, which is implanted using a less-invasive procedure than traditional open-heart surgery. The company's shares rose $3.31, or 3.8 percent, to $89.83 in morning trading on the New York Stock Exchange. Edwards, which released the outlook in conjunction with its annual investor conference at its headquarters in Irvine, California, said it expects global sales of its transcatheter heart valve of $710 million to $790 million in 2013. The company forecast 2013 earnings per share, excluding special items, of $3.21 to $3.31, an increase of more than 25 percent over projected 2012 earnings. It expects total sales next year of $2.1 billion to $2.2 billion.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions